-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$33.861453.21% Upside
Ventyx Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Ventyx Biosciences, Inc.?
Ventyx Biosciences, Inc. has been rated by research analysts at H.C. Wainwright, Oppenheimer, Wells Fargo, Goldman Sachs, Morgan Stanley, Jefferies in the past 90 days.